ParkerVision, Inc.
ParkerVision, Inc. (PRKR) Financial Performance & Income Statement Overview
Explore the financials of ParkerVision, Inc. (PRKR), including yearly and quarterly data on income, cash flow, and balance sheets.
ParkerVision, Inc. (PRKR) Income Statement & Financial Overview
Analyze ParkerVision, Inc.’s PRKR earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | -$59000.00 |
| Cost of Revenue | $55000.00 | $57000.00 | $58000.00 | $60000.00 |
| Gross Profit | -$55000.00 | -$57000.00 | -$58000.00 | -$119000.00 |
| Gross Profit Ratio | $2.02 | |||
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.82M | $980000.00 | $683000.00 | $713000.00 |
| Operating Expenses | $1.82M | $980000.00 | $683000.00 | $772000.00 |
| Total Costs & Expenses | $1.88M | $1.04M | $741000.00 | $832000.00 |
| Interest Income | $52000.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $85000.00 | $101000.00 | $104000.00 | $104000.00 |
| Depreciation & Amortization | $55000.00 | $58000.00 | $58000.00 | $60000.00 |
| EBITDA | -$2.50M | -$10.65M | -$165000.00 | -$529000.00 |
| EBITDA Ratio | $8.97 | |||
| Operating Income | -$1.88M | -$1.04M | -$741000.00 | -$832000.00 |
| Operating Income Ratio | $14.10 | |||
| Other Income/Expenses (Net) | -$765000.00 | -$9.77M | $414000.00 | $139000.00 |
| Income Before Tax | -$2.65M | -$10.81M | -$327000.00 | -$693000.00 |
| Income Before Tax Ratio | $11.75 | |||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $16724.00 |
| Net Income | -$2.65M | -$10.81M | -$327000.00 | -$693000.00 |
| Net Income Ratio | $11.75 | |||
| EPS | -$0.03 | -$0.12 | -$0.004 | -$0.008 |
| Diluted EPS | -$0.03 | -$0.12 | -$0.004 | -$0.008 |
| Weighted Avg Shares Outstanding | $109.02M | $90.34M | $88.68M | $88.16M |
| Weighted Avg Shares Outstanding (Diluted) | $109.02M | $90.34M | $88.68M | $88.16M |
Over the past four quarters, ParkerVision, Inc. demonstrated steady revenue growth, increasing from -$59000.00 in Q1 2024 to $0.00 in Q4 2024. Operating income reached -$1.88M in Q4 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$2.50M, reflecting operational efficiency. Net income rose to -$2.65M, with EPS at -$0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan